Mental Health Professionals' Attitudes Toward Digital Mental Health Apps and Implications for Adoption in Portugal: Mixed Methods Study
- PMID: 37266977
- PMCID: PMC10276319
- DOI: 10.2196/45949
Mental Health Professionals' Attitudes Toward Digital Mental Health Apps and Implications for Adoption in Portugal: Mixed Methods Study
Abstract
Background: Digital health apps are among the most visible facets of the ongoing digital transition in health care, with mental health-focused apps as one of the main therapeutic areas. However, concerns regarding their scientific robustness drove regulators to establish evaluation procedures, with Germany's Digitale Gesundheitsanwendungen program pioneering in app prescription with costs covered by statutory health insurance. Portugal gathers a set of conditions and requirements that position it as an excellent test bed for digital health apps. Its daunting mental health landscape reinforces the potential interest in new interventions. To understand if they would be acceptable, we need to understand the supply side's attitudes and perceptions toward them, that is, those of psychiatrists and psychologists.
Objective: This study aims to understand the attitudes and expectations of psychiatrists and psychologists toward digital mental health apps (DMHAs) in the Portuguese context, as well as perceived benefits, barriers, and actions to support their adoption.
Methods: We conducted a 2-stage sequential mixed methods study. Stage 1 consisted of a cross-sectional web survey adapted to the Portuguese context that was delivered to mental health professionals and psychologists. Stage 2 complemented the insights of the web survey results with a key opinion leader analysis.
Results: A total of 160 complete survey responses were recorded, most of which were from psychologists. This is the most extensive study on mental health professionals' attitudes and perceptions of DMHAs in Portugal. A total of 87.2% (136/156) of the respondents supported the opportunity to prescribe DMHAs. Increased health literacy (139/160, 86.9%), wider adherence to treatment (137/160, 85.6%), and proper disease management (127/160, 79.4%) were the most frequently agreed upon benefits of DMHAs. However, only less than half (68/156, 43.6%) of the respondents planned to prescribe or recommend DMHAs, with psychologists being more favorable than psychiatrists. Professionals faced substantial barriers, such as a lack of information on DMHAs (154/160, 96.3%), the level of initial training effort (115/160, 71.9%), and the need for adjustments of clinical processes and records (113/160, 70.6%). Professionals reported that having more information on the available apps and their suitability for health objectives (151/160, 94.4%), more scientific evidence of the validity of the apps as a health intervention (147/160, 91.9%), and established recommendations of apps by specific clinical guidelines or professional societies (145/160, 90.6%) would be essential to foster adoption.
Conclusions: More information about DMHAs regarding their clinical validity and how they work is necessary so that such an intervention can be adopted in Portugal. Recommendations from professional and scientific societies, as well as from governmental bodies, are strongly encouraged. Although the benefits of and the barriers to using these apps are consensual, more evidence, along with further promotion of mental health professionals' digital literacy, is needed.
International registered report identifier (irrid): RR2-10.2196/41040.
Keywords: adoption; apps; digital health; government regulation; health policy; mHealth; mental health; mobile health; psychiatrists; psychologists; technology acceptance.
©Diogo Nogueira-Leite, José Miguel Diniz, Ricardo Cruz-Correia. Originally published in JMIR Human Factors (https://humanfactors.jmir.org), 02.06.2023.
Conflict of interest statement
Conflicts of Interest: This study was conducted as part of the doctoral research project at the Health Data Science PhD Program, Faculty of Medicine of the University of Porto, Portugal. Two authors participated in this project while employed by the Faculty of Medicine of the University of Porto, as DN-L and RC-C were working on a project cofunded by the European Union concerning the digitalization of clinical trials in the north of Portugal (CR—Digital: Digitize clinical research in the North of Portugal NORTE-01-0145-FEDER-083448). The European-funded project or the Faculty of Medicine of the University of Porto were at no point involved in the research, aside from the required administrative approvals. There was also no funding, pay, or other commercial interest provided by the Faculty of Medicine of the University of Porto, aside from the costs related to the publication of this paper. The help received from Knok healthcare regarding the dissemination of the survey questionnaire entailed no reception or use of financial benefits or otherwise. All work concerning this study was conducted during the authors’ personal time.
Figures





Similar articles
-
Individuals' attitudes toward digital mental health apps and implications for adoption in Portugal: web-based survey.BMC Med Inform Decis Mak. 2024 Apr 18;24(1):99. doi: 10.1186/s12911-024-02488-1. BMC Med Inform Decis Mak. 2024. PMID: 38637866 Free PMC article.
-
Physicians' Attitudes Toward Prescribable mHealth Apps and Implications for Adoption in Germany: Mixed Methods Study.JMIR Mhealth Uhealth. 2021 Nov 23;9(11):e33012. doi: 10.2196/33012. JMIR Mhealth Uhealth. 2021. PMID: 34817385 Free PMC article.
-
Attitudes of Physicians and Individuals Toward Digital Mental Health Tools: Protocol for a Web-Based Survey Research Project.JMIR Res Protoc. 2023 Mar 14;12:e41040. doi: 10.2196/41040. JMIR Res Protoc. 2023. PMID: 36917172 Free PMC article.
-
Smartphone applications for depression: a systematic literature review and a survey of health care professionals' attitudes towards their use in clinical practice.Eur Arch Psychiatry Clin Neurosci. 2020 Mar;270(2):139-152. doi: 10.1007/s00406-018-0974-3. Epub 2019 Jan 3. Eur Arch Psychiatry Clin Neurosci. 2020. PMID: 30607530
-
The Potential of Self-Management mHealth for Pediatric Cystic Fibrosis: Mixed-Methods Study for Health Care and App Assessment.JMIR Mhealth Uhealth. 2019 Apr 18;7(4):e13362. doi: 10.2196/13362. JMIR Mhealth Uhealth. 2019. PMID: 30998222 Free PMC article. Review.
Cited by
-
Acceptance of online therapy for children and adolescents with digital media use disorders: perspectives from child and adolescent psychiatrists and psychotherapists in Germany.Eur Child Adolesc Psychiatry. 2025 Jul;34(7):2215-2227. doi: 10.1007/s00787-025-02640-w. Epub 2025 Jan 13. Eur Child Adolesc Psychiatry. 2025. PMID: 39800830 Free PMC article.
-
Mobile health for mental health support: a survey of attitudes and concerns among mental health professionals in Poland over the period 2020-2023.Front Psychiatry. 2024 Mar 15;15:1303878. doi: 10.3389/fpsyt.2024.1303878. eCollection 2024. Front Psychiatry. 2024. PMID: 38559395 Free PMC article.
-
Use of Online Tools for Mental Health Among Racially and Ethnically Diverse College Students: Mixed Methods Study.JMIR Hum Factors. 2025 Jun 13;12:e60628. doi: 10.2196/60628. JMIR Hum Factors. 2025. PMID: 40513094 Free PMC article.
References
-
- How health apps are promising to reshape healthcare. McKinsey & Company. 2017. Feb 03, [2022-11-08]. https://www.mckinsey.com/industries/life-sciences/our-insights/how-healt... .
-
- El-Sherif DM, Abouzid M. Analysis of mHealth research: mapping the relationship between mobile apps technology and healthcare during COVID-19 outbreak. Global Health. 2022 Jun 28;18(1):67. doi: 10.1186/s12992-022-00856-y. https://globalizationandhealth.biomedcentral.com/articles/10.1186/s12992... 10.1186/s12992-022-00856-y - DOI - DOI - PMC - PubMed
-
- Digital Health Trends 2021. IQVIA. 2022. [2022-11-01]. https://www.iqvia.com/insights/the-iqvia-institute/reports/digital-healt... .
-
- Dahlhausen F, Zinner M, Bieske L, Ehlers JP, Boehme P, Fehring L. There's an app for that, but nobody's using it: insights on improving patient access and adherence to digital therapeutics in Germany. Digit Health. 2022 Jul 3;8:20552076221104672. doi: 10.1177/20552076221104672. https://journals.sagepub.com/doi/abs/10.1177/20552076221104672?url_ver=Z... 10.1177_20552076221104672 - DOI - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous